COVID-19 Disease Severity and Blood Test Results in Unvaccinated and Vaccinated Patients at Bhayangkara Hospital, Denpasar, Indonesia

Chanif Lutfiyati Muyasaroh, Ngurah Intan, Wiratmini, Anak Agung, Sagung Alit, Sukmaningsih
{"title":"COVID-19 Disease Severity and Blood Test Results in Unvaccinated and Vaccinated Patients at Bhayangkara Hospital, Denpasar, Indonesia","authors":"Chanif Lutfiyati Muyasaroh, Ngurah Intan, Wiratmini, Anak Agung, Sagung Alit, Sukmaningsih","doi":"10.20473/fmi.v59i2.43810","DOIUrl":null,"url":null,"abstract":"Highlights:\n\nThis original research report on the differences in disease severity and blood test results between unvaccinated and vaccinated COVID-19 patients is quite novel, as the COVID-19 pandemic was still happening when this study was carried out. \nThis original research report offers information on the advantages of the COVID-19 vaccines and provides data that the public may use as scientific evidence to counter hoaxes. \n\nAbstract\nThe COVID-19 pandemic caused by SARS-CoV-2 is an unprecedented event in human history. Vaccines are a safe, long-term solution for addressing the COVID-19 pandemic. This study aimed to investigate the differences in disease severity and blood test results between unvaccinated and vaccinated COVID-19 patients. This study used an analytical observational method with purposive sampling. A total of 90 COVID-19 patients at Bhayangkara Hospital, Denpasar, Indonesia, were divided into three groups: unvaccinated group (V0), two-dose vaccinated group (Vp), and three-dose vaccinated group (Vb). Primary data were collected from July to December 2022, while secondary data were collected from January 2021 to June 2022. The data were analyzed using the Kruskal-Wallis test followed by the Mann-Whitney test, as well as one-way ANOVA test followed by Tukey's honestly significant difference (HSD) test with a confidence interval (CI) of 95% and α of 5%. The results revealed significant differences in disease severity (p<0.001). V0 had a higher percentage of severe (36.7%) and critical (6.7%) symptoms than Vp (severe=10.0%; critical, n=0) and Vb (severe and critical, n=0). The follow-up tests revealed significant differences in disease severity between V0 and Vp (p<0.001), V0 and Vb (p<0.001), as well as Vp and Vb (p=0.001). Blood test results revealed significant differences in lymphocytes (p=0.005), monocytes (p<0.001), monocyte-to-lymphocyte ratio (MLR) (p<0.001), and eosinophils (p=0.037). The follow-up tests revealed significant differences in these four indicators between V0 and Vb, in all parameters except for lymphocytes between V0 and Vp, and in lymphocytes only between Vp vs Vb. In conclusion, unvaccinated patients had a higher percentage of severe and critical symptoms than vaccinated patients. The blood test results revealed significant differences in lymphocytes, monocytes, MLR, and eosinophils. Unvaccinated patients had lower lymphocyte counts, higher MLR levels, and higher monocyte counts than vaccinated patients. ","PeriodicalId":32666,"journal":{"name":"Folia Medica Indonesiana","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Folia Medica Indonesiana","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20473/fmi.v59i2.43810","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Highlights: This original research report on the differences in disease severity and blood test results between unvaccinated and vaccinated COVID-19 patients is quite novel, as the COVID-19 pandemic was still happening when this study was carried out.  This original research report offers information on the advantages of the COVID-19 vaccines and provides data that the public may use as scientific evidence to counter hoaxes.  Abstract The COVID-19 pandemic caused by SARS-CoV-2 is an unprecedented event in human history. Vaccines are a safe, long-term solution for addressing the COVID-19 pandemic. This study aimed to investigate the differences in disease severity and blood test results between unvaccinated and vaccinated COVID-19 patients. This study used an analytical observational method with purposive sampling. A total of 90 COVID-19 patients at Bhayangkara Hospital, Denpasar, Indonesia, were divided into three groups: unvaccinated group (V0), two-dose vaccinated group (Vp), and three-dose vaccinated group (Vb). Primary data were collected from July to December 2022, while secondary data were collected from January 2021 to June 2022. The data were analyzed using the Kruskal-Wallis test followed by the Mann-Whitney test, as well as one-way ANOVA test followed by Tukey's honestly significant difference (HSD) test with a confidence interval (CI) of 95% and α of 5%. The results revealed significant differences in disease severity (p<0.001). V0 had a higher percentage of severe (36.7%) and critical (6.7%) symptoms than Vp (severe=10.0%; critical, n=0) and Vb (severe and critical, n=0). The follow-up tests revealed significant differences in disease severity between V0 and Vp (p<0.001), V0 and Vb (p<0.001), as well as Vp and Vb (p=0.001). Blood test results revealed significant differences in lymphocytes (p=0.005), monocytes (p<0.001), monocyte-to-lymphocyte ratio (MLR) (p<0.001), and eosinophils (p=0.037). The follow-up tests revealed significant differences in these four indicators between V0 and Vb, in all parameters except for lymphocytes between V0 and Vp, and in lymphocytes only between Vp vs Vb. In conclusion, unvaccinated patients had a higher percentage of severe and critical symptoms than vaccinated patients. The blood test results revealed significant differences in lymphocytes, monocytes, MLR, and eosinophils. Unvaccinated patients had lower lymphocyte counts, higher MLR levels, and higher monocyte counts than vaccinated patients. 
印度尼西亚登巴萨Bhayangkara医院未接种疫苗和接种疫苗患者的新冠肺炎疾病严重程度和血液检测结果
要点:这份关于未接种疫苗和接种疫苗的新冠肺炎患者之间疾病严重程度和血液检测结果差异的原始研究报告非常新颖,因为在进行这项研究时,新冠肺炎大流行仍在发生。这份原始研究报告提供了有关新冠肺炎疫苗优势的信息,并提供了公众可以用作科学证据来对抗恶作剧的数据。摘要由SARS-CoV-2引起的新冠肺炎大流行是人类历史上前所未有的事件。疫苗是应对新冠肺炎大流行的安全、长期解决方案。本研究旨在调查未接种疫苗和接种疫苗的新冠肺炎患者在疾病严重程度和血液检测结果方面的差异。这项研究采用了一种有目的抽样的分析观察方法。在印度尼西亚登巴萨Bhayangkara医院,共有90名新冠肺炎患者被分为三组:未接种疫苗组(V0)、两剂疫苗组(Vp)和三剂接种组(Vb)。主要数据收集于2022年7月至12月,次要数据收集于2021年1月至2022年6月。使用Kruskal-Wallis检验和Mann-Whitney检验,以及单因素方差分析检验和Tukey诚实显著性差异(HSD)检验对数据进行分析,置信区间(CI)为95%,α为5%。结果显示,疾病严重程度存在显著差异(p<0.001)。V0的严重症状(36.7%)和危重症状(6.7%)的比例高于Vp(严重=10.0%;危重,n=0)和Vb(严重和危重,n=0)。随访测试显示,V0和Vp(p<0.001)、V0和Vs(p<0.01)以及Vp和Vb(p=0.001)之间的疾病严重程度存在显著差异。血液测试结果显示,淋巴细胞(p=0.005)、单核细胞(p<001)、,和嗜酸性粒细胞(p=0.037)。随访测试显示,V0和Vb之间的这四个指标,除V0和vs之间的淋巴细胞外的所有参数,以及仅Vp和Vsb之间的淋巴细胞存在显著差异。总之,未接种疫苗的患者比接种疫苗的人有更高比例的严重和危重症状。血液测试结果显示淋巴细胞、单核细胞、MLR和嗜酸性粒细胞存在显著差异。未接种疫苗的患者比接种疫苗的病人淋巴细胞计数更低,MLR水平更高,单核细胞计数更高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
45
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信